Recent Finacing
Recent Raise
Ensysce Biosciences is a clinical-stage biopharmaceutical company developing abuse-deterrent opioid analgesics, spearheaded by its Phase 3 candidate PF614.
Focus Areas
Recent Investors
Valuation as of 11/17/2025
Total Raised
Funding rounds
Investors
